Tag: AI in Drug Discovery
-
Enhertu’s Phase 3 Win: AI Accelerates Lung Cancer Treatment
Enhertu’s Phase 3 trial success in treating lung cancer highlights the critical role AI played in optimizing the drug’s development. This marks a significant step in personalized medicine, offering new hope for targeted cancer treatments. Read more
-
In Vivo CAR-T: Revolutionizing Cancer Treatment with AI
The advent of in vivo CAR-T therapy marks a transformative milestone in cancer treatment by engineering immune cells directly within the body. AI optimizes this process, promising improved scalability and reduced costs in treating blood cancers. Read more
-
AI’s Role in Protein Folding: Promise and Pitfalls
Recent studies reveal that AI tools for predicting protein structures, like AlphaFold2, sometimes produce unrealistic results due to overlooking fundamental scientific principles. Integrating physics-based validation with AI predictions is essential for accurate modeling. Read more
